Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported selling a total of 29,113 shares of common stock on March 12, 2026 in open-market transactions. Footnotes state these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades. After these sales, she continues to hold 963,702 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. Chief Executive Officer John E. Kao reported selling a total of 48,899 shares of common stock in open-market transactions on March 12, 2026. The shares were sold at weighted-average prices of $17.476 and $16.9919 per share.
According to the disclosure, these sales were required to cover tax withholding obligations triggered by the vesting of restricted stock units and did not represent discretionary trading decisions by Mr. Kao. After the transactions, he held 1,519,480 shares directly.
The filing also reports 2,472,641 shares of common stock held indirectly through the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee, providing additional indirect economic exposure to Alignment Healthcare stock.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported a Form 4 showing a bona fide gift of 4,200 shares of common stock to family members on March 10, 2026. The transaction carried no sale price, and she now directly holds 992,815 shares after the gift.
Alignment Healthcare, Inc. notice of sale of 69,541 shares of Common Stock. The filing lists the sale date as 12/29/2025 and an aggregate transaction amount of $1,303,384.48.
The shares were acquired on 03/08/2022 upon vesting of restricted stock units granted under the 2021 Equity Incentive Plan. The filing identifies the seller as Robert L. Scavo.
Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements. The filing lists multiple executed or scheduled dispositions by Dawn Maroney, including sales of 100,000 shares on 01/02/2026 and 228,152 shares on 01/06/2026. Shares outstanding were 204,296,493 as of 03/11/2026.
Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure. The filing lists multiple 10b5-1 plan sales including 180,000 shares on 03/10/2026, 180,000 on 02/10/2026, 180,000 on 01/12/2026, and a 605,648-share sale on 12/29/2025. It also shows 124,172 shares acquired from RSU vesting on 03/08/2022.
Alignment Healthcare, Inc. director and CEO John E. Kao reported an open-market sale of 180,000 shares of common stock at a weighted-average price of $18.1864 per share on March 10, 2026. The shares were held indirectly through the JEK Trust, where he serves as trustee. Following the sale, indirect holdings reported for the trust were 2,472,641 shares, and his direct holdings were 1,568,379 shares. The transaction was executed under a Rule 10b5-1 trading plan adopted on March 12, 2025.
JEK TRUST reported a proposed sale of 180,000 shares of Common Stock in a Form 144 filing. The filing lists an aggregate amount of $3,279,600.00 and references NASDAQ trading with a context figure of 204,296,493 shares and the date 03/10/2026.
The excerpt also shows prior 10b5-1 activity by the same trust: sales of 180,000 shares on 02/10/2026 and 01/12/2026 (amounts listed), and an earlier sale of 605,648 shares on 12/29/2025. The filing lists Morgan Stanley Smith Barney LLC in the securities section.
Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock in an open-market transaction on March 4, 2026 at a weighted-average price of $18.6216 per share.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025, with individual trade prices ranging from $18.47 to $18.89 per share. Following this transaction, Wagner directly owns 148,687 Alignment Healthcare shares.
ALHC affiliate filed a Form 144 to sell restricted stock units. The filing lists 21,118 restricted stock units associated with the issuer dated 03/13/2025. The filing also reports that Andreas Wagner sold 22,238 common shares on 02/10/2026 for $455,211.86.